[MeMed in MeMed] MeMed awarded $2 million grant to establish a first-of-Its-kind acute care digital and physical biobank

HAIFA, Israel, Jan. 12, 2026 /PRNewswire/ — MeMed, the leader in host-response diagnostics, announced it has been awarded a competitive national grant through the IIA to establish an acute-care diagnostics and proteomics biobank, as part of a nationwide AI R&D data infrastructure. This initiative significantly accelerates the development and validation of next-generation AIVD™ (Artificial Intelligence In Vitro Diagnostics) for high-risk patients by combining acute-care biospecimens with linked clinical data and high-resolution immune profiling.

Read more here.